Alane P. Barnes is CLO at BIOCRYST PHARMACEUTICALS INC (BCRX). They have made 7 open-market trades across 1 company since 2014, most recently 2026-05-13.
CIK 0001584348
2 open-market purchases totalling $57K since 2019, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCRX | 400,703 | $3.1M |
Shares reported on the most recent Form 4, priced at the 2026-05-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCRX | SELL · 10b5-1 | 2026-05-13 | 2026-05-15 | $9.54 | $596K | +1.0% | +0.7% | +8.7% |
| BCRX | SELL · 10b5-1 | 2026-03-16 | 2026-03-18 | $9.15 | $1.4M | +3.3% | +3.8% | -2.5% |
| BCRX | SELL · 10b5-1 | 2025-12-22 | 2025-12-23 | $7.65 | $333K | +1.3% | -9.8% | +31.0% |
| BCRX | SELL · 10b5-1 | 2025-12-15 | 2025-12-16 | $7.65 | $325K | +3.8% | -3.5% | +25.2% |
| BCRX | SELL · 10b5-1 | 2025-12-01 | 2025-12-03 | $7.20 | $2.3M | -3.3% | -4.5% | +10.7% |
| BCRX | BUY | 2024-05-13 | 2024-05-15 | $5.53 | $28K | -3.3% | -3.6% | +23.3% |
| BCRX | SELL · 10b5-1 | 2022-12-15 | 2022-12-19 | $10.88 | $45K | +8.8% | -4.2% | -24.1% |
| BCRX | SELL | 2021-05-11 | 2021-05-13 | $12.04 | $2.5M | +10.1% | +35.0% | +29.1% |
| BCRX | SELL | 2020-12-11 | 2020-12-15 | $7.96 | $219K | -15.0% | +1.7% | +59.5% |
| BCRX | SELL | 2020-12-04 | 2020-12-08 | $6.23 | $171K | +12.0% | +0.7% | +44.3% |
| BCRX | BUY | 2019-11-18 | 2019-11-18 | $1.45 | $29K | +60.1% | +77.5% | +64.3% |
| BCRX | SELL | 2018-11-30 | 2018-12-04 | $9.07 | $803K | -9.7% | -8.3% | -1.3% |
| BCRX | SELL · 10b5-1 | 2016-09-14 | 2016-09-16 | $4.27 | $36K | +4.4% | -11.3% | +23.8% |
| BCRX | SELL · 10b5-1 | 2015-06-19 | 2015-06-22 | $15.00 | $45K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2014-03-04 | 2014-03-07 | $12.63 | $514K | -26.4% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.